AbbVie (NYSE: ABBV) today announced positive results from a new post-hoc analysis from the Measure Up 1 and Measure Up 2 Phase 3 studies. The analysis evaluated the efficacy of upadacitinib (15 mg or ...
rash, bumps, or sores, a board-certified dermatologist can diagnose the underlying condition," said Dr. Massick. "Often, itching can have more than one cause, and together we can work toward a ...
Saint Louis University's School of Medicine has a long tradition of excellence in medical school, graduate medical education and graduate education. Established in 1836, the school has the distinction ...